MedPath

Baxter AG

🇨🇭Switzerland
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.baxter.ch

Clinical Trials

14

Active:14
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

22

CANADA:8
PHILIPPINES:3
CIMA_AEMPS:3

Drug Approvals

VEPACEL SUSPENSION INYECTABLE

Approval Date
Jul 14, 2025
Company
Baxter Innovations GmbH
CIMA_AEMPS

VACUNA GRIPE PANDEMICA H5N1 BAXTER

Approval Date
Jul 14, 2025
CIMA_AEMPS

VACUNA GRIPE PANDEMICA H5N1 BAXTER

Approval Date
Jul 14, 2025
CIMA_AEMPS

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.